Albemarle Corporation (ALB)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Albemarle is recovering with revenue growing from $1.1B in 2025-Q1 to $1.4B in 2026-Q1. Adjusted EBITDA rose from $267M to $664M in the same period. The company plans to keep capital spending flat around $550M to $600M in 2026. These show progress toward stabilizing and improving profitability.
Albemarle remains volatile and loss-making with a high PE of 55. Margins and earnings have been inconsistent, with recent misses and a sharp stock selloff. The turnaround may stall if revenue growth or EBITDA targets are not sustained.
The market prices in about 11% revenue growth and values the stock roughly 15% below our fair value of $152. Our fair value is 38% below the Street median, reflecting caution on profitability and execution risks.
Breaks if: Adjusted EBITDA falls below $900 million in FY26
Breaks if: Capital expenditures exceed $600 million or fall below $550 million in FY26
Annual revenue falls below $4.1 billion in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. ALB is navigating a volatile management phase while aiming for consistent revenue and EBITDA targets in a competitive materials sector.
The market currently prices ALB at a premium compared to its peers, reflecting justified expectations. There is a low expectations gap, indicating that the market does not assume significant upside or downside from current performance.
Management is on track to meet its revenue and EBITDA targets for 2026, although capital expenditures show mixed results. Recent financial performance has been neutral, with a low probability of missing guidance, but historical volatility in earnings remains a concern.
The long-term thesis hinges on management's ability to maintain guidance and navigate recent leadership transitions. Additionally, sector performance, particularly from major peers, and macroeconomic factors like inflation will play critical roles in shaping ALB's trajectory.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company maintained its revenue guidance for 2026, which supports the read. However, the transition to a new CEO may impact strategic execution and revenue guidance. Additionally, a revised earnings outlook from RBC poses a challenge to the company's guidance.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, ALB's performance will depend on effective management execution and favorable sector conditions. Not investment advice.